Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI-522 in active rheumatoid arthritis
NCT00069017Phase 2Completed
- Sponsor
- MedImmune
- Start
- Sep 2003
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of etaracizumab in rheumatoid arthritis (RA), sponsored by MedImmune. Started Sep 2003; status: completed.
02
Drugs
etaracizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00069017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069017.